x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Psychopharmacology and Psychiatry Updates

Psychopharmacology Institute

Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.

health & fitness medicine

All Episodes

13:34

Rethinking Antipsychotic Dosing: Lessons from the...

Psychopharmacology and Psychiatry Updates ·

2025/01/06

In this episode, we explore the RADAR trial's findings on antipsychotic dose reduction in schizophrenia. Can patients with chronic schizophrenia safely reduce or discontinue their antipsychotic medications without increasing relapse risk? The trial's results challenge common assumptions about medication reduction and provide crucial guidance for clinical practice. Faculty: Oliver Freudenreich, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CME: Quick Take Vol. 62

en

11:06

Unraveling Agitation: Mania vs. Substance Use

Psychopharmacology and Psychiatry Updates ·

2025/01/01

In this episode, we explore the challenges of diagnosing and managing agitation in emergency settings, focusing on mood disorders and substance use. Dr. Scott Zeller shares insights on differentiating acute mania from substance-induced psychosis. How can clinicians navigate the complex interplay between psychiatric symptoms and substance effects in emergencies? Faculty: Scott Zeller, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1.25 CME: The Psychopharmacology of

en

11:00

Pushing the Boundaries: Exploring High-Dose...

Psychopharmacology and Psychiatry Updates ·

2024/12/27

In this episode, we explore the use of high-dose olanzapine as a potential alternative to clozapine for treatment-resistant schizophrenia. We discuss a systematic review that examines the efficacy and safety of olanzapine doses above the FDA-approved maximum. Could high-dose olanzapine be a viable option when patients refuse clozapine? Faculty: Oliver Freudenreich, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CMEs: Quick Take Vol. 61 Is High-Dose Olanzapine an

en

15:19

The Psychodynamic Prescriber

Psychopharmacology and Psychiatry Updates ·

2024/12/22

In this episode, we explore how integrating psychodynamic principles into pharmacotherapy can enhance treatment outcomes. We discuss seven key features of psychodynamic psychotherapy and their application in routine psychiatric practice. How might understanding a patient's fantasies about their illness impact their response to medication? Faculty: David Mintz, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1 CME: Psychodynamic Psychopharmacology: Alliance, Communication,

en

09:43

From Inpatient to Outpatient: Initiating...

Psychopharmacology and Psychiatry Updates ·

2024/12/17

In this episode, we explore strategies for discontinuing benzodiazepines in hospitalized elderly patients. We discuss a recent Israeli study that tested two interventions during inpatient stays. Can a simple hospital-based intervention lead to successful long-term medication changes? Faculty: Paul Zarkowski, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CMEs: Quick Take Vol. 61 Stopping Benzodiazepines and Z-Drugs in Hospitalized Elderly Patients

en

14:14

The Power of Alliance in Psychopharmacology

Psychopharmacology and Psychiatry Updates ·

2024/12/12

In this episode, we explore the critical role of therapeutic alliance in psychopharmacology. We discuss how factors like empathy, communication, and shared decision-making can significantly impact treatment outcomes. Did you know that a doctor's warm voice can increase appointment adherence by 162%? Faculty: David Mintz, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1 CME: Psychodynamic Psychopharmacology: Alliance, Communication, and Psychotherapy Skills

en

08:27

Antipsychotics in Youth: Balancing Metabolic Risk

Psychopharmacology and Psychiatry Updates ·

2024/12/07

In this episode, we explore the cardiac and metabolic safety profile of antipsychotics in youth, based on a World Health Organization Safety Database analysis. We discuss age-dependent risks, specific medication concerns, and the importance of monitoring. How can clinicians balance the benefits of antipsychotics with potential cardiometabolic risks in young patients? Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CMEs: CAP Smart Takes Vol. 20

en

12:29

The Double-Edged Sword of Biological Explanations in...

Psychopharmacology and Psychiatry Updates ·

2024/12/02

In this episode, we explore the unexpected consequences of promoting a purely biological view of mental illness. How does framing mental health conditions as solely biological affect stigma, patient outcomes, and physician empathy? We delve into the complex interplay between biological and psychosocial factors in mental health treatment. Faculty: David Mintz, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1 CME: Psychodynamic Psychopharmacology: Alliance, Communication,

en

11:15

New Insights into Psychiatric and Cardiovascular...

Psychopharmacology and Psychiatry Updates ·

2024/11/27

In this episode, we explore the bidirectional relationship between psychiatric disorders and cardiovascular disease, discussing a groundbreaking study involving over 900,000 subjects. We ask: Can a mental health diagnosis increase your risk of heart disease? Faculty: Scott Beach, M.D. Host: Richard Seeber, M.D. Learn more about our membership her Earn 0.5 CMEs: Quick Take Vol. 60 Psychiatric Disorders and Subsequent Risk of Cardiovascular Disease

en

16:55

Beyond the Pill: The Psychology of Psychopharmacology

Psychopharmacology and Psychiatry Updates ·

2024/11/22

In this episode, we explore the science behind the art of psychopharmacotherapy with Dr. David Mintz. We delve into how psychosocial factors, including the prescriber's approach, can significantly impact medication outcomes. Did you know that some psychiatrists achieve better results with placebos than others do with active medications? Faculty: David Mintz, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1 CME: Psychodynamic Psychopharmacology: Alliance, Communication,

en

09:20

On Methylphenidate and Sleep: A Two-Year Study

Psychopharmacology and Psychiatry Updates ·

2024/11/17

In this episode, we explore the long-term effects of methylphenidate on sleep in children and adolescents with ADHD. Can stimulant medication actually improve sleep in ADHD patients? We dive into surprising research findings that challenge common assumptions about ADHD treatment and sleep disturbances. Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CMEs: CAP Smart Takes Vol. 20 Long-Term Effects of Methylphenidate on Sleep in Children and

en

09:01

Nature's Pharmacy: Combining Natural Remedies in...

Psychopharmacology and Psychiatry Updates ·

2024/11/12

In this episode, we explore the strategic use of natural medications in psychiatry, focusing on combination therapies for various mental health conditions. Dr. David Mischoulon discusses potential synergies between natural remedies and conventional drugs, as well as all-natural combinations. But how do we balance efficacy with safety when using these less-studied treatments? Faculty: David Mischoulon, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 0.75 CME: Natural

en

10:13

Breaking the Cycle: Memantine in Body-Focused...

Psychopharmacology and Psychiatry Updates ·

2024/11/07

In this episode, we explore the use of memantine in treating trichotillomania and skin picking disorder. Could this common Alzheimer's medication be the breakthrough we've been waiting for in managing body-focused repetitive behaviors? Dr. Bob Hudak discusses a promising study that offers new hope for patients struggling with these often-overlooked conditions. Faculty: Robert Hudak, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CMEs: Quick Take Vol. 60 Efficacy of

en

07:48

The Potential of Ashwagandha in Psychiatry

Psychopharmacology and Psychiatry Updates ·

2024/11/02

In this episode, we explore Ashwagandha, a versatile natural remedy in psychiatry. We discuss its potential applications in treating anxiety, depression, OCD, and other mental health disorders. Could this ancient herb be the key to managing treatment-resistant patients? Faculty: David Mischoulon, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 0.75 CME: Natural Medication in Psychiatry: Focus on Versatile Agents and Combination Strategies Ashwagandha (ASW): Potential

en

10:46

Treatment Dilemmas: ECT for Depressed Teens

Psychopharmacology and Psychiatry Updates ·

2024/10/28

In this episode, we explore the controversial use of electroconvulsive therapy (ECT) in adolescents with severe depression and suicidality. We discuss a study examining ECT's effectiveness, factors influencing outcomes, and its potential as a treatment option. Is ECT a viable last resort for treatment-resistant depression in teens? Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CMEs: CAP Smart Takes Vol. 19 Electroconvulsive Therapy for

en

09:37

CBD in Psychiatry: Promise or Hype?

Psychopharmacology and Psychiatry Updates ·

2024/10/23

In this episode, we explore the potential uses of Cannabidiol (CBD) in psychiatric practice. We discuss its mechanisms, evidence for various disorders, and guidelines for safe use. Is CBD the next breakthrough in mental health treatment, or just another passing trend? Faculty: David Mischoulon, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 0.75 CME: Natural Medication in Psychiatry: Focus on Versatile Agents and Combination Strategies Cannabidiol: Evidence for

en

08:56

Beyond Dopamine: Cannabidiol in Parkinson's Care

Psychopharmacology and Psychiatry Updates ·

2024/10/18

In this episode, we explore the use of medical cannabis in treating Parkinson's disease. We discuss a retrospective study that reveals promising results for both motor and non-motor symptoms. Could medical cannabis be the versatile solution we've been seeking for Parkinson's treatment? Faculty: Gregory Pontone, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CMEs: Quick Take Vol. 59 Medical Cannabis in the Treatment of Parkinson’s Disease

en

07:58

Is NAC Promising in Bipolar and Depression Treatment?

Psychopharmacology and Psychiatry Updates ·

2024/10/13

In this episode, we explore the potential of N-acetylcysteine (NAC) in treating mood disorders. We discuss its mechanism of action, clinical evidence for its use in depression and bipolar disorder, and its possible benefits for both adults and children. Could this natural compound revolutionize our approach to mood stabilization? Faculty: David Mischoulon, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 0.75 CME: Natural Medication in Psychiatry: Focus on Versatile Agents

en

09:48

Microbes and the Mind: Probiotics and ADHD

Psychopharmacology and Psychiatry Updates ·

2024/10/08

In this episode, we explore the potential use of probiotics in treating ADHD symptoms in children and adolescents. Could the gut microbiome hold the key to managing this complex neurodevelopmental disorder? We discuss a recent meta-analysis and its implications for future research and clinical practice. Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CMEs: CAP Smart Takes Vol. 19 Efficacy of Probiotics in Treating ADHD Symptoms

en

09:32

Lithium, Lamotrigine, and Labor: Managing Bipolar...

Psychopharmacology and Psychiatry Updates ·

2024/10/03

In this episode, we explore the challenges and best practices for managing bipolar disorder during pregnancy. We discuss key medications, their risks and benefits, and the importance of individualized treatment plans. How do we balance maternal mental health with fetal safety when treating bipolar disorder in pregnant women? Faculty: Vivien Burt, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1 CME: Perinatal Treatment of Bipolar Disorder Guiding Principles for Treating

en

411 results

Similar Podcasts

Доктор Тройняшкин

Доктор Тройняшкин

The Dry Eye Treatment PODCAST

Dry Eye Treatment

Différent et alors ?

PATRICK SULAY

Kyle Kingsbury Podcast

Kyle Kingsbury

The Real Weight Loss Coach

Matty Lansdown